Latest Financial Impact News

Imricor Medical Systems made significant regulatory strides with FDA submissions for its MRI-guided cardiac ablation devices and launched NorthStar commercially in Europe, even as it reported increased cash outflows in Q3 CY25.

Service Stream has delivered a robust FY25 performance with revenue growth, record profits, and a landmark $1.6 billion Defence contract, setting the stage for continued expansion.

Etherstack has secured a £14.2 million contract with the UK Home Office to provide critical software for the Emergency Services Network, reinforcing its global leadership in public safety communications.

Memphasys Limited has disclosed a $1.118 million liability linked to its FY24 R&D tax rebate following an ASX inquiry, while confirming compliance with continuous disclosure rules and ongoing engagement with the ATO for a private ruling.

PWR Holdings has announced significant board changes following its AGM, with founder Kees Weel stepping down as Managing Director to become Chairman, alongside new appointments to key governance roles.

Saunders International has landed a $19.8 million contract to build 11 tanks at a gold processing facility, reinforcing its foothold in the resources sector and promising revenue growth over the next two years.

Forrestania Resources has completed its strategic acquisition of First Western Gold, securing control over seven exploration licenses including the promising Burracoppin Gold Project in Western Australia.

Mayne Pharma has won a key legal battle against Cosette Pharmaceuticals, clearing the way for its acquisition scheme to proceed pending final approvals. Shareholders can expect the deal to move forward with payments scheduled soon.

Treasury Wine Estates reported robust fiscal 2025 results driven by luxury wine growth and acquisitions, yet has downgraded its fiscal 2026 earnings outlook due to weakening demand in China and distribution disruptions in California.

EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.

Peppermint Innovation Limited (PIL) has addressed recent unusual trading activity, attributing it to growing market recognition of its recent fintech milestones rather than undisclosed information.

Audeara Limited has landed its maiden purchase order for hearing aid technology in China, marking a pivotal step in its global expansion with production and launch planned for the final quarter of 2025.